Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
One of greatest challenges to the successful treatment of cancer is drug resistance. An exciting approach is the eradication of cancer stem cells (CSCs). However, little is known about key signals regulating the formation and expansion of CSCs. Moreover, lack of a reliable predictive preclinical model has been a major obstacle to discover new cancer drugs and predict their clinical activity. Here, in ovarian cancer, a highly chemoresistant tumor that is rapidly fatal, we provide the first evidence demonstrating the causal involvement of mechanical stimulus in the CSC phenotype using a customizable microfluidic platform and three-dimensional spheroids, which most closely mimic tumor behavior. We found that ovarian cancer cells significantly acquired the expression of epithelial-to-mesenchymal transition and CSC markers and a remarkable chemoresistance to clinically relevant doses of frontline chemotherapeutic drugs cisplatin and paclitaxel when grown under fluid shear stress, which corroborates with the physiological attainable levels in the malignant ascites, but not under static condition. Furthermore, we uncovered a new link of microRNA-199a-3p, phosphatidylinositol 3-kinase/Akt and multidrug transporter activation in shear stress-induced CSC enrichment. Our findings shed new light on the significance of hydrodynamics in cancer progression, emphasizing the need of a flow-informed framework in the development of therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It was found that fluid shear stress could prompt ovarian cancer cell dissemination, enrich cancer stem cell population as well as enhance tumor's chemoresistance to anti-cancer drugs.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [156]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [115]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [115]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,853
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
The biology of ovarian cancer: new opportunities for translation
Bast, R. C., Hennessy, B., & Mills, G. B. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2644 · Cited by 1,358
Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
Zhang, S., Balch, C., Chan, M. W., Lai, H.-C., Matei, D., Schilder, J. M., Yan, P. S., Huang, T. H.-M., & Nephew, K. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0364 · Cited by 1,293
Bapat, S. A., Mali, A. M., Koppikar, C. B., & Kurrey, N. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3931 · Cited by 760
Szotek, P. P., Pieretti-Vanmarcke, R., Masiakos, P. T., Dinulescu, D. M., Connolly, D., Foster, R., Dombkowski, D., Preffer, F., MacLaughlin, D. T., & Donahoe, P. K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603672103 · Cited by 751
PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application.
Pu, X., & Xu, X. (2015) · Europe PMC (PubMed Central) · Cited by 453
HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells
Knuefermann, C., Lu, Y., Liu, B., Jin, W., Liang, K., Wu, L., Schmidt, M., Mills, G. B., Mendelsohn, J., & Fan, Z. (2003) · Oncogene · doi:10.1038/sj.onc.1206394 · Cited by 452
Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation
Kumar, S. M., Liu, S., Lu, H., Zhang, H., Zhang, P. J., Gimotty, P. A., Guerra, M., Guo, W., & Xu, X. (2012) · Oncogene · doi:10.1038/onc.2011.656 · Cited by 308
Myungjin Lee, J., Mhawech-Fauceglia, P., Lee, N., Cristina Parsanian, L., Gail Lin, Y., Andrew Gayther, S., & Lawrenson, K. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.41 · Cited by 301
Research works printed but not linked: 1
- White, F. M. Viscous fluid flow. 2nd edn, Ch. 3, 104–211 (McGraw-Hill, 1974).
Cited by
New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment
Chen, S.-H., & Chang, J.-Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174136 · Cited by 428
Moshksayan, K., Kashaninejad, N., Warkiani, M. E., Lock, J. G., Moghadas, H., Firoozabadi, B., Saidi, M. S., & Nguyen, N.-T. (2018) · Sensors and Actuators B: Chemical · doi:10.1016/j.snb.2018.01.223 · Cited by 267
The Untapped Potential of Ascites in Ovarian Cancer Research and Treatment
Ford, C. E., Werner, B., Hacker, N. F., & Warton, K. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0875-x · Cited by 261
“There is also broader evidence that ascites is involved in promoting epithelial-to-mesenchymal transition (EMT), by shifting cancer cells towards a stem-cell-like phenotype.(38,51,52) Cancer stem cells have the capacity to self-renew and differentiate, reducing their vulnerability to chemotherapy, especially in sphero…”
Loret, N., Denys, H., Tummers, P., & Berx, G. (2019) · Cancers · doi:10.3390/cancers11060838 · Cited by 247
Microfluidic modelling of the tumor microenvironment for anti-cancer drug development
Shang, M., Soon, R. H., Lim, C. T., Khoo, B. L., & Han, J. (2019) · Lab on a Chip · doi:10.1039/c8lc00970h · Cited by 227
Jo, Y., Choi, N., Kim, K., Koo, H.-J., Choi, J., & Kim, H. N. (2018) · Theranostics · doi:10.7150/thno.29098 · Cited by 183
Rickard, B. P., Conrad, C., Sorrin, A. J., Ruhi, M. K., Reader, J. C., Huang, S. A., Franco, W., Scarcelli, G., Polacheck, W. J., Roque, D. M., et al. (2021) · Cancers · doi:10.3390/cancers13174318 · Cited by 184
Beyond matrix stiffness: targeting force-induced cancer drug resistance
Kalli, M., Poskus, M. D., Stylianopoulos, T., & Zervantonakis, I. K. (2023) · Trends in Cancer · doi:10.1016/j.trecan.2023.07.006 · Cited by 167
Decarli, M. C., do Amaral, R. L. F., dos Santos, D. P., Tofani, L. B., Katayama, E. T., Rezende, R. A., da Silva, J. V. L., Swiech, K., Suazo, C. A. T., Mota, C., et al. (2021) · Biofabrication · doi:10.1088/1758-5090/abe6f2 · Cited by 154
Extracellular Matrix Cues Regulate Mechanosensing and Mechanotransduction of Cancer Cells
Mierke, C. T. (2024) · Cells · doi:10.3390/cells13010096 · Cited by 146
The Ever-Evolving Concept of the Cancer Stem Cell in Pancreatic Cancer
Valle, S., Martin-Hijano, L., Alcalá, S., Alonso-Nocelo, M., & Sainz Jr., B. (2018) · Cancers · doi:10.3390/cancers10020033 · Cited by 121
Glutathione in Ovarian Cancer: A Double-Edged Sword
Nunes, S. C., & Serpa, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071882 · Cited by 119
Tumor–Host Cell Interactions in Ovarian Cancer: Pathways to Therapy Failure
Pogge von Strandmann, E., Reinartz, S., Wager, U., & Müller, R. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2016.12.005 · Cited by 100
Cellular landscaping of cisplatin resistance in cervical cancer
Bhattacharjee, R., Dey, T., Kumar, L., Kar, S., Sarkar, R., Ghorai, M., Malik, S., Jha, N. K., Vellingiri, B., Kesari, K. K., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113345 · Cited by 93
Hyler, A. R., Baudoin, N. C., Brown, M. S., Stremler, M. A., Cimini, D., Davalos, R. V., & Schmelz, E. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194170 · Cited by 92
Mechanics and Actomyosin-Dependent Survival/Chemoresistance of Suspended Tumor Cells in Shear Flow
Xin, Y., Chen, X., Tang, X., Li, K., Yang, M., Tai, W., Liu, Y., & Tan, Y. (2019) · Biophysical Journal · doi:10.1016/j.bpj.2019.04.011 · Cited by 91
Integrated cancer tissue engineering models for precision medicine
Bregenzer, M. E., Horst, E. N., Mehta, P., Novak, C. M., Raghavan, S., Snyder, C. S., & Mehta, G. (2019) · PLOS ONE · doi:10.1371/journal.pone.0216564 · Cited by 82
Ovarian cancer stem cells and their role in drug resistance
Pieterse, Z., Amaya-Padilla, M. A., Singomat, T., Binju, M., Ardyansyah, B. D., Yu, Y., & Kaur, P. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.11.012 · Cited by 85
Novak, C. M., Horst, E. N., Taylor, C. C., Liu, C. Z., & Mehta, G. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27119 · Cited by 75
Triantafillu, U. L., Park, S., Klaassen, N. L., Raddatz, A. D., & Kim, Y. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3865 · Cited by 77
The revolution of PDMS microfluidics in cellular biology
Banik, S., Uchil, A., Kalsang, T., Chakrabarty, S., Ali, M. A., Srisungsitthisunti, P., Mahato, K. K., Surdo, S., & Mazumder, N. (2023) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2022.2034733 · Cited by 84
“cultured 3D spheroids of ovarian carcinoma cells into straight and pressure-driven PDMS microchannels (Figure 4b1) [130].”
BackgroundThe impact of microfluidics in high-throughput drug-screening applications
Stefano, P. D., Bianchi, E., & Dubini, G. (2022) · Biomicrofluidics · doi:10.1063/5.0087294 · Cited by 83
Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity
Nunes, S. C., Ramos, C., Lopes‐Coelho, F., Sequeira, C. O., SILVA, F. A. B. N. D., Gouveia-Fernandes, S., Rodrigues, A., Guimarães, A., Silveira, M., Abreu, S. C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-27753-y · Cited by 81
Mechanical Control of Cell Proliferation Increases Resistance to Chemotherapeutic Agents
Rizzuti, I. F., Mascheroni, P., Arcucci, S., Ben-Mériem, Z., Prunet, A., Barentin, C., Rivière, C., Delanoë-Ayari, H., Hatzikirou, H., Guillermet-Guibert, J., et al. (2020) · Physical Review Letters · doi:10.1103/physrevlett.125.128103 · Cited by 72
Circulating tumour cells in the -omics era: how far are we from achieving the ‘singularity’?
Visal, T. H., den Hollander, P., Cristofanilli, M., & Mani, S. A. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01768-9 · Cited by 78
Advanced technological tools to study multidrug resistance in cancer
Andrei, L., Kasas, S., Ochoa, I., Stanković, T., Korsnes, M. S., Václavíková, R., Assaraf, Y. G., & Pešić, M. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100658 · Cited by 74
The Role of Cancer Stem Cells and Mechanical Forces in Ovarian Cancer Metastasis
Bregenzer, M. E., Horst, E. N., Mehta, P., Novak, C. M., Repetto, T., & Mehta, G. (2019) · Cancers · doi:10.3390/cancers11071008 · Cited by 64
Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas
Griso-Acevedo, A. B., Acero-Riaguas, L., Castelo, B., Carretero, J. L. C., & Sastre-Perona, A. (2022) · Cells · doi:10.3390/cells11030561 · Cited by 72
The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination
Ritch, S. J., & Telleria, C. M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.886533 · Cited by 70
Targeting the tumour microenvironment in platinum-resistant ovarian cancer
Cummings, M., Freer, C., & Orsi, N. M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.02.007 · Cited by 69
Zhu, H., Gu, X. Q., Xia, L., Zhou, Y., Bouamar, H., Yang, J., Ding, X., Zwieb, C. W., Zhang, J., Hinck, A. P., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3112 · Cited by 69
Review: Mechanotransduction in ovarian cancer: Shearing into the unknown
Novak, C. M., Horst, E. N., & Mehta, G. (2018) · APL Bioengineering · doi:10.1063/1.5024386 · Cited by 68
Yee, C., Dickson, K.-A., Muntasir, M. N., Ma, Y., & Marsh, D. J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.836984 · Cited by 66
Wilczyński, J. R., Wilczyński, M., & Paradowska, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052496 · Cited by 65
Bridging the gap between tumor-on-chip and clinics: a systematic review of 15 years of studies
Bouquerel, C., Dubrova, A., Hofer, I., Phan, D. T. T., Bernheim, M., Ladaigue, S., Cavaniol, C., Maddalo, D., Cabel, L., Mechta-Grigoriou, F., et al. (2023) · Lab on a Chip · doi:10.1039/d3lc00531c · Cited by 58
Hassan, A. A., Artemenko, M., Tang, M. K. S., Shi, Z., Chen, L., Lai, H.-C., Yang, Z., Shum, H.-C., & Wong, A. S. T. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04976-6 · Cited by 58
Self-citationMasiello, T. J., Dhall, A., Hemachandra, L. P. M. P., Tokranova, N. A., Melendez, J. A., & Castracane, J. (2018) · Cells · doi:10.3390/cells7120277 · Cited by 56
Engineering Breast Cancer On-chip—Moving Toward Subtype Specific Models
Moccia, C., & Haase, K. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.694218 · Cited by 51
Novak, C. M., Horst, E. N., Lin, E., & Mehta, G. (2020) · Cancers · doi:10.3390/cancers12061521 · Cited by 47
“Within ovarian cancer, the influences of mechanotransduction are not thoroughly understood, and while a majority of studies focus on fluid shear stress, compressive stress remains relatively unexplored [35,36].”
BackgroundDroplet Microarray on Patterned Butterfly Wing Surfaces for Cell Spheroid Culture
Shao, C., Liu, Y., Chi, J., Chen, Z., Wang, J., & Zhao, Y. (2019) · Langmuir · doi:10.1021/acs.langmuir.8b03884 · Cited by 47
Sialyl Lewisx-P-selectin cascade mediates tumor–mesothelial adhesion in ascitic fluid shear flow
Li, S., Ip, C. K. M., Tang, M. Y. H., Tang, M. K. S., Tong, Y., Zhang, J., Hassan, A. A., Mak, A. S. C., Yung, S., Chan, T. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10334-6 · Cited by 46
Self-citationAdvances in numerical approaches for microfluidic cell analysis platforms
Sheidaei, Z., Akbarzadeh, P., & Kashaninejad, N. (2020) · Journal of Science Advanced Materials and Devices · doi:10.1016/j.jsamd.2020.07.008 · Cited by 45
Collins, T., Pyne, E. S., Christensen, M., Iles, A., Pamme, N., & Pires, I. M. (2021) · Biomicrofluidics · doi:10.1063/5.0061373 · Cited by 42
Modeling Ovarian Cancer Multicellular Spheroid Behavior in a Dynamic 3D Peritoneal Microdevice
Li, S., Ip, C. K. M., Tang, M. Y. H., Sy, S. K. H., Yung, S., Chan, T. M., Yang, M., Shum, H. C., & Wong, A. S. T. (2017) · Journal of Visualized Experiments · doi:10.3791/55337 · Cited by 40
Self-citationVillalta, M., Sánchez, A., Herrera, M., Vargas, M., Segura, Á., Cerdas, M., Estrada, R., Gawarammana, I., Keyler, D. E., McWhorter, K. A., et al. (2016) · Toxicon · doi:10.1016/j.toxicon.2016.10.007 · Cited by 39
Fang, Z., Li, T., Chen, W., Wu, D., Qin, Y., Liu, M., Wu, G. J., He, L., Li, H., & Gu, H. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.06.007 · Cited by 37
3D fluid-dynamic ovarian cancer model resembling systemic drug administration for efficacy assay
Marrella, A. (2020) · ALTEX · doi:10.14573/altex.2003131 · Cited by 36
Nunes, S. C., Lopes‐Coelho, F., Gouveia-Fernandes, S., Ramos, C., Pereira, S. A., & Serpa, J. (2018) · BMC Evolutionary Biology · doi:10.1186/s12862-018-1214-1 · Cited by 35
Ovarian Biomechanics: From Health to Disease
Sun, C. H., Yang, X., Wang, T., Cheng, M., & Han, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.744257 · Cited by 33
Jobst, M., Kiss, E., Gerner, C., Marko, D., & Favero, G. D. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03375-2 · Cited by 33
Zhang, Y., O’Mahony, A. P., He, Y., & Barber, T. J. (2024) · Biofabrication · doi:10.1088/1758-5090/ad22ee · Cited by 31
Understanding the effect of mechanical forces on ovarian cancer progression
Martinez, A., Buckley, M., Scalise, C. B., Katre, A. A., Dholakia, J., Crossman, D. K., Birrer, M. J., Berry, J. L., & Arend, R. C. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.04.003 · Cited by 28
Experimental models for ovarian cancer research
Tsang, S. I., Hassan, A. A., To, S. K. Y., & Wong, A. S. T. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113150 · Cited by 27
Self-citationHagihara, T., Kondo, J., Endo, H., Ohue, M., Sakai, Y., & Inoue, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-56739-7 · Cited by 27
Horst, E. N., Bregenzer, M. E., Mehta, P., Snyder, C. S., Repetto, T., Yang‐Hartwich, Y., & Mehta, G. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.04.041 · Cited by 27
Rane, A., Jarmoshti, J., Siddique, A., Adair, S. J., Torres‐Castro, K., Honrado, C., Bauer, T. W., & Swami, N. S. (2023) · Lab on a Chip · doi:10.1039/d3lc00804e · Cited by 26
Engineering Mechanical Microenvironment of Macrophage and Its Biomedical Applications
Li, J., Li, Y., Gao, B., Qin, C., He, Y., Xu, F., Yang, H., & Lin, M. (2018) · Nanomedicine · doi:10.2217/nnm-2017-0324 · Cited by 26
Luo, W., Yang, G., Qiu, J., Luan, J., Zhang, Y., You, L., Feng, M., Zhao, F., Liu, Y., Cao, Z., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2384 · Cited by 25
Effects of biomechanical forces on the biological behavior of cancer stem cells
Tian, B. R., Lin, W., & Zhang, Y. (2021) · Journal of Cancer · doi:10.7150/jca.60893 · Cited by 25
The Role of Tumor Microenvironment in Regulating the Plasticity of Osteosarcoma Cells
Tian, B., Du, X., Zheng, S., & Zhang, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416155 · Cited by 24
Dash, S. K., Patra, B., Sharma, V., Das, S. K., & Verma, R. S. (2022) · Lab on a Chip · doi:10.1039/d1lc01139a · Cited by 23
In Vitro Models of Ovarian Cancer: Bridging the Gap between Pathophysiology and Mechanistic Models
Lopez, E., Kamboj, S., Chen, C., Wang, Z., Kellouche, S., Leroy‐Dudal, J., Carreiras, F., Lambert, A., & Aimé, C. (2023) · Biomolecules · doi:10.3390/biom13010103 · Cited by 23
The progressive trend of modeling and drug screening systems of breast cancer bone metastasis
Azar, H. K., Gharibshahian, M., Rostami, M., Mansouri, V., Sabouri, L., Beheshtizadeh, N., & Rezaei, N. (2024) · Journal of Biological Engineering · doi:10.1186/s13036-024-00408-5 · Cited by 23
The Roles of Exosomes in Ovarian Cancer Chemo-resistance
Liu, Y., Xiao, L., Zhang, T., & Liu, G. (2023) · Journal of Cancer · doi:10.7150/jca.84930 · Cited by 22
Plesselova, S., Calar, K., Axemaker, H., Sahly, E., Bhagia, A., Faragher, J. L., Fink, D. M., & de la Puente, P. (2024) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-024-00817-y · Cited by 21
Mendoza-Martinez, A. K., Loessner, D., Mata, Á., & Azevedo, H. S. (2021) · Cancers · doi:10.3390/cancers13225745 · Cited by 21
VSV based virotherapy in ovarian cancer: the past, the present and …future?
Orzechowska, B., Jędryka, M., Zwolińska, K., & Matkowski, R. (2017) · Journal of Cancer · doi:10.7150/jca.19473 · Cited by 21
Perspective on the Application of Microphysiological Systems to Drug Transporter Studies
Caetano-Pinto, P., & Stahl, S. H. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.082750 · Cited by 21
Bileck, A., Bortel, P., Kriz, M., Janker, L., Kiss, E., Gerner, C., & Favero, G. D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.746411 · Cited by 21
Barisam, M., Ranjbar-Niavol, F., Kinj, M. A., Saidi, M. S., Ghanbarian, H., & Kashaninejad, N. (2022) · Journal of Science Advanced Materials and Devices · doi:10.1016/j.jsamd.2022.100439 · Cited by 21
Schneider, I., Baumgartner, W., Gröninger, O. G., Stark, W. J., Märsmann, S., Calcagni, M., Cinelli, P., Wolint, P., & Buschmann, J. (2019) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2019.103481 · Cited by 19
Marjamaa, A., Gibbs, B. E., Kotrba, C., & Masamha, C. P. (2023) · Scientific Reports · doi:10.1038/s41598-023-44548-y · Cited by 19
Triantafillu, U. L., Park, S., & Kim, Y. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800112 · Cited by 18
Gupta, P., Miller, A. F., Olayanju, A., Madhuri, T. K., & Velliou, E. G. (2022) · Cancers · doi:10.3390/cancers14051274 · Cited by 18
Novel Ex Vivo Models of Epithelial Ovarian Cancer: The Future of Biomarker and Therapeutic Research
Clark, J., Fotopoulou, C., Cunnea, P., & Krell, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.837233 · Cited by 17
Karasová, M., Jobst, M., Framke, D., Bergen, J., Meier, S. M., Keppler, B. K., Koellensperger, G., Zanghellini, J., Gerner, C., & Favero, G. D. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02144-9 · Cited by 17
YTHDF1 targets the chemotherapy response by suppressing NOTCH1-induced stemness in colorectal cancer
Cheung, H., Chen, H., Chen, D. M., Zhou, H., Liang, C., Liu, W., Cheung, A. H. K., Ding, Y., Yuan, K., Li, X., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02507-1 · Cited by 15
MiRNAs: main players of cancer drug resistance target ABC transporters
Mohammadi, F., Nejatollahi, M., Sheikhnia, F., Ebrahimi, Y., Mohammadi, M., Rashidi, V., Alizadeh‐Fanalou, S., Azizzadeh, B., & Majidinia, M. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03719-y · Cited by 15
Battistini, C., & Cavallaro, U. (2023) · Cancers · doi:10.3390/cancers15020368 · Cited by 15
Shukla, D., Mishra, S., Mandal, T., Charan, M., Verma, A. K., Khan, M. M. A., Chatterjee, N., Dixit, A. K., Ganesan, S. K., Ganju, R. K., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07430-5 · Cited by 14
Lv, Z., Wang, H., Liu, X.-P., Jin, L., Shen, R., Wang, X., Kong, B., Qu, H., Li, F., & Yang, Q. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479542 · Cited by 14
RetractedGera, S., Sandeep Kumar, S., Swamy, S. N., Bhagat, R., Vadaparty, A., Gawari, R., Bhat, R., & Dighe, R. R. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00272 · Cited by 14
Does resource availability help determine the evolutionary route to multicellularity?
Hamant, O., Bhat, R., Nanjundiah, V., & Newman, S. A. (2019) · Evolution & Development · doi:10.1111/ede.12287 · Cited by 13
Payne, M. C., Ho, S. Y., Hashimoto, T., Imboden, S., Diaz, J. A., Lee, B. S., Rupert, M. J., Cai, N., Goldstein, A. S., & Lin, N. Y. C. (2023) · Biotechnology Journal · doi:10.1002/biot.202200434 · Cited by 12
Wang, J., Gao, Q., Zhang, Q., Hao, L., Jiang, J., Huyan, L.-Y., Liu, B.-Q., Yan, J. Y., Li, C. R., & Wang, H. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119076 · Cited by 12
The Balance Between Shear Flow and Extracellular Matrix in Ovarian Cancer‐on‐Chip
Chen, C., Boché, A., Wang, Z., Lopez, E., Peng, J., Carreiras, F., Schanne‐Klein, M., Chen, Y., Lambert, A., & Aimé, C. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400938 · Cited by 11
Mechanical Modulation of Ovarian Cancer Tumor Nodules Under Flow
Conrad, C., Moore, K., Polacheck, W. J., Rizvi, I., & Scarcelli, G. (2021) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2021.3092641 · Cited by 11
Autophagy modulation changes mechano-chemical sensitivity of T24 bladder cancer cells
Jobst, M., Hossain, M., Kiss, E., Bergen, J., Marko, D., & Favero, G. D. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115942 · Cited by 10
Naour, A. L., Mével, R., Thibault, B., Courtais, E., Chantalat, É., Delord, J. P., Couderc, B. C., Guillermet‐Guibert, J., & Martínez, A. (2018) · Oncotarget · doi:10.18632/oncotarget.25513 · Cited by 10
Ruhi, M. K., Rickard, B. P., Overchuk, M., Sinawang, P. D., Stanley, M. E., Mansi, M., Sierra, R. G., Hayes, B., Tan, X. M., Akin, D., et al. (2024) · Photochemistry and Photobiology · doi:10.1111/php.14014 · Cited by 9
Transient fluid flow improves photoimmunoconjugate delivery and photoimmunotherapy efficacy
Sorrin, A. J., Zhou, K., May, K., Liu, C., McNaughton, K. A., Rahman, I., Liang, B. J., Rizvi, I., Roque, D. M., & Huang, H. (2023) · iScience · doi:10.1016/j.isci.2023.107221 · Cited by 9
Overchuk, M., Rickard, B. P., Tulino, J., Tan, X. M., Ligler, F. S., Huang, H., & Rizvi, I. (2024) · Photochemistry and Photobiology · doi:10.1111/php.13967 · Cited by 9
Mechanical activation and expression of HSP27 in epithelial ovarian cancer
Buckley, M., Kramer, M., Johnson, B. M., Huskin, G. N., Berry, J. L., & Sewell-Loftin, M. K. (2024) · Scientific Reports · doi:10.1038/s41598-024-52992-7 · Cited by 8
A Circulating Bioreactor Reprograms Cancer Cells Toward a More Mesenchymal Niche
Çalamak, S., Ermis, M., Sun, H., Islam, S., Sikora, M. J., Nguyen, M., Hasırcı, V., Steinmetz, L. M., & Demirci, U. (2020) · Advanced Biosystems · doi:10.1002/adbi.201900139 · Cited by 8
Metastatic organotropism in peritoneal metastasis: Paget’s hypothesis revisited
Kim, D., Kaushal, D., & Wilson, R. B. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01868-9 · Cited by 7
LKB1 and STRADα Promote Epithelial Ovarian Cancer Spheroid Cell Invasion
Trelford, C. B., Buensuceso, A. V., Tomas, E. J., Valdés, Y. R., Hovey, O. F. J., Li, S. S. ‐., & Shepherd, T. G. (2024) · Cancers · doi:10.3390/cancers16223726 · Cited by 6
Self-citationChen, Y., Xue, Y., Xu, L., Li, W., Chen, Y., Zheng, S., Dai, R., & Liu, J. (2022) · Lab on a Chip · doi:10.1039/d2lc00631f · Cited by 6
Canda, A. E., Sever, T., Calibasi‐Kocal, G., Başbınar, Y., & Ellıdokuz, H. (2024) · Pleura and Peritoneum · doi:10.1515/pp-2023-0033 · Cited by 5
Ren, Y., Huang, Y., Xie, C., Yan, Y., Wang, J., & Yamaguchi, T. (2021) · Heat Transfer Engineering · doi:10.1080/01457632.2021.1943853 · Cited by 5
Self-citationSheidaei, Z., Akbarzadeh, P., Nguyen, N., & Kashaninejad, N. (2022) · Biomedical Microdevices · doi:10.1007/s10544-022-00615-1 · Cited by 5
Metadata
- Authors
- Ip, C. K. M., Li, S.-S., Tang, M. Y. H., Sy, S. K. H., Ren, Y., Shum, H. C., & Wong, A. S. T.
- Affiliations
- University of Hong Kong (HK)
- University of Nottingham Ningbo China (CN)
- Corresponding author
- Shum, Ho Cheung
- Wong, Alice S. T.
- Venue
- Scientific Reports
- Published
- 2016-06-01
- Volume
- 6
- Issue
- 1
- Pages
- 26788-26788
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4887794
- OpenAlex
- W2411989512
- Semantic Scholar
- 3de6a4bc8956ea6c48d1d158c7368c0ae7adc0aa
- Cited by
- 128
- References
- 43
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 13 · 2023: 15 · 2022: 25 · 2021: 12 · 2020: 9 · 2019: 16 · 2018: 16 · 2017: 5 · 2016: 1
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by-nc-nd)
- Nottingham ePrints (University of Nottingham) (submittedVersion, cc-by-nc-nd)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion, cc-by-nc-nd)
- Funders
- Chinese University of Hong Kong
- NYU Polytechnic School of Engineering
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- epithelial ovarian cancer, cancer stem cells, chemoresistance, fluid shear stress, mechanical stimulation, epithelial-mesenchymal transition, cisplatin resistance, paclitaxel resistance, PI3K/Akt signaling, multidrug transporter, multicellular spheroids, microfluidic platform, malignant ascites
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily G, Member 2, Animals, Ascites, Carcinoma, Female, Humans, Mice, Inbred BALB C, Mice, Nude, Neoplasm Proteins, Ovarian Neoplasms, RNA, Neoplasm, Tumor Cells, Cultured, Neoplastic Stem Cells, Signal Transduction, Spheroids, Cellular, Drug Resistance, Neoplasm, ATP Binding Cassette Transporter, Subfamily B, Member 1, Shear Strength, MicroRNAs, Mice, Lab-On-A-Chip Devices, Hydrodynamics, Epithelial-Mesenchymal Transition, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.